Tom Leemhuis

Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer

Robert S. Negrin, K Atkinson, Tom Leemhuis et al. · Biology of Blood and Marrow Transplantation · 2000 · 164 citations · Full text

Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma

Mauricette Michallet, Thierry Philip, Irène Philip et al. · Experimental Hematology · 2000 · 111 citations · Full text

Cell Therapy, Transplantation, Marrow Transplantation +11

An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

Rebecca Marsh, Mi‐Ok Kim, Chunyan Liu et al. · Biology of Blood and Marrow Transplantation · 2013 · 73 citations · Full text

Lymphoid Neoplasia, Cell Therapy, Transplantation +8

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen

Rebecca Marsh, Marepalli B. Rao, Aharon Gefen et al. · Biology of Blood and Marrow Transplantation · 2015 · 72 citations · Full text

Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.

Guido Tricot, Tom Leemhuis, Edwin Walker et al. · PubMed · 1989 · 47 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Mixed-phenotype Acute Leukemia +13